"Update on FDA's ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity"
The postbiotic component may support gut health during the GI adjustment period common with GLP-1 medications
The primary endpoint will be bodyweight change (week 80 and 104), change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in the OA subset, and change in Apnoea-Hypopnea Index (AHI) in the OSA subset
Citing 2020 research conducted by Chinas National Health Commission, the company noted that over half of the countrys adults were overweight or obese, which was described as a severe issue by the commissions deputy director L Bn at the time of the reports release
The differentiator is what happens after and alongside medication: MEDVi monitors your metabolic health
If you are considering GLP-1 medications, consult your healthcare provider to explore your options